Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
Okwonna
Alexander C
AC
Sansgiry
Sujit S
SS
D003362:Cost-Benefit Analysis; D006495:Heparin, Low-Molecular-Weight / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D010919:Placebos; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control
D006495:Heparin, Low-Molecular-Weight; D010919:Placebos